Professor Sian E Harding

Sian Harding is Professor of Cardiac Pharmacology at Imperial College London and Director of the British Heart Foundation Cardiovascular Regenerative Medicine Centre there. Her work has centred on the myocardium in heart failure, especially beta-adrenergic mechanisms. She was Scientific PI on the first UK Gene therapy Trial in LVAD patients, aimed at improving cardiac contractility. She is now studying the pluripotent stem cell-derived cardiomyocyte, both for disease modelling and cardiac repair. Professor Harding is former President of the European Section of the International Society for Heart Research and Board member of the British Society of Gene and Cell Therapy. She is on the Stem Cell Advisory panel for the Cell and Gene Therapy Catapult.